Hong Luo

TL;DR: Radiological and physiological abnormalities were still found in a considerable proportion of COVID-19 survivors without critical cases 3 months after discharge, and higher level of D-dimer levels on admission could effectively predict impaired DLCO after 3 months discharge.

TL;DR: Wang et al. as discussed by the authors investigated the potential of the oral microbiome as a non-invasive biomarker for COVID-19 and explored correlations between the microbiome and lipid profile by collecting and sequencing 392 tongue-coating samples, 172 faecal samples and 155 serum samples from Central China and East China.

TL;DR: The preliminary results show that FNC treatment in the mild and common CO VID‐19 may shorten the NANC time versus standard antiviral treatment, and clinical trials of FNC treating COVID‐19 with larger sample size are warranted.

TL;DR: In this article, the authors evaluated the long-term consequences of COVID-19 survivors one year after recovery, and identified the risk factors associated with abnormal patterns in chest imaging manifestations or impaired lung function.

TL;DR: Wang et al. as mentioned in this paper studied the characterization of oropharyngeal microbiome in recovered coronavirus disease 2019 (COVID-19) patients and then completed MiSeq sequencing.